IceCure Medical Ltd

IceCure Medical is an Israeli medical device company founded in 2006 to advance treatment of cancerous tumors. IceCure’s core technology is based on cryoablation, using freezing temperature (liquid nitrogen) to destroy tumors safely, quickly, and painlessly without the need for surgery. IceCure’s next generation cryoablation technology, the ProSense system, enables rapid minimally-invasive, safe, and effective treatment of breast lesions in-office or ambulatory hospital settings. The ProSense system provides physicians with full control over the procedure, ensuring that the treated zone is destroyed while leaving surrounding tissue undamaged.